Close Menu

NEW YORK (GenomeWeb) — German molecular diagnostics firm Curetis said today that it will receive €6.5 million ($7.3 million) in gross proceeds under two financing facilities.

According to Curetis, it will receive a €5.0 million tranche of non-dilutive debt financing under a loan deal signed with the European Investment Bank in late 2016. The company also said it will now be able to access €1.5 million under a €20 million convertible notes financing facility signed with Yorkville Advisors Global in October.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.